A Phase 1, randomized, double-blind, sponsor-open study to describe the safety and tolerability of a multivalent Pneumococcal Conjugate Vaccine in adults
Clinical Trial Grant
Awarded By
Pfizer, Inc.
Start Date
October 3, 2025
End Date
October 2, 2026
Awarded By
Pfizer, Inc.
Start Date
October 3, 2025
End Date
October 2, 2026